Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 162.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 163.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 172,463
  • Market Cap: £173.37m
  • RiskGrade: 484

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
8.76% above the market average8.76% above the market average8.76% above the market average8.76% above the market average8.76% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr Revenue Growth
2.8% below the market average2.8% below the market average2.8% below the market average2.8% below the market average2.8% below the market average
15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average15.15% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
59.91% below the market average59.91% below the market average59.91% below the market average59.91% below the market average59.91% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average
1yr DPS Growth
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
40.78% below the market average40.78% below the market average40.78% below the market average40.78% below the market average40.78% below the market average
76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average
Price Book Ratio
42.91% below the market average42.91% below the market average42.91% below the market average42.91% below the market average42.91% below the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
93.62% above the market average93.62% above the market average93.62% above the market average93.62% above the market average93.62% above the market average
95.00% above the sector average95.00% above the sector average95.00% above the sector average95.00% above the sector average95.00% above the sector average
Price Chg 3m
75.33% above the market average75.33% above the market average75.33% above the market average75.33% above the market average75.33% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
92.58% above the market average92.58% above the market average92.58% above the market average92.58% above the market average92.58% above the market average
94.87% above the sector average94.87% above the sector average94.87% above the sector average94.87% above the sector average94.87% above the sector average
Momentum 20
84.94% above the market average84.94% above the market average84.94% above the market average84.94% above the market average84.94% above the market average
94.87% above the sector average94.87% above the sector average94.87% above the sector average94.87% above the sector average94.87% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
19.24% below the market average19.24% below the market average19.24% below the market average19.24% below the market average19.24% below the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average
ROCE
56.72% above the market average56.72% above the market average56.72% above the market average56.72% above the market average56.72% above the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
25.52% above the market average25.52% above the market average25.52% above the market average25.52% above the market average25.52% above the market average
57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average
Forecast EPS
29.11% below the market average29.11% below the market average29.11% below the market average29.11% below the market average29.11% below the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
41.72% above the market average41.72% above the market average41.72% above the market average41.72% above the market average41.72% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
Operating Profit Loss
21.09% above the market average21.09% above the market average21.09% above the market average21.09% above the market average21.09% above the market average
42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
25.70% above the market average25.70% above the market average25.70% above the market average25.70% above the market average25.70% above the market average
42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average42.11% above the sector average
Cash
1.33% below the market average1.33% below the market average1.33% below the market average1.33% below the market average1.33% below the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral
91.05% above the market average91.05% above the market average91.05% above the market average91.05% above the market average91.05% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 162.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 163.50
52 Week Low 101.00
Volume 172,463
Shares Issued 106.69m
Market Cap £173.37m
RiskGrade 484

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.92% below the market average85.92% below the market average85.92% below the market average85.92% below the market average85.92% below the market average
2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average2.7% below the sector average
Price Trend
85.68% above the market average85.68% above the market average85.68% above the market average85.68% above the market average85.68% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income
77.3% below the market average77.3% below the market average77.3% below the market average77.3% below the market average77.3% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Growth
31.17% below the market average31.17% below the market average31.17% below the market average31.17% below the market average31.17% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 10-Jul-2020

Time Volume / Share Price
16:21 46,461 @ 162.08p
14:42 8,389 @ 162.00p
14:41 8,389 @ 162.00p
12:58 48,000 @ 162.00p
12:53 68,000 @ 162.16p

Cello Health Key Personnel

CEO Mark Scott

Top of Page